What other stocks do shareholders of Anatara Lifesciences own?

Anatara Lifesciences (ANR) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ANR Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 3,950 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Anatara Lifesciences alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Anatara Lifesciences

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry in water. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

Click for my No. 1 investment, all free of charge, click here.

ANR Stock News Headlines

January 23, 2024 | forbes.com

Edwards Lifesciences

October 5, 2023 | wsj.com

Eris Lifesciences Ltd.

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

August 9, 2023 | finance.yahoo.com

Edwards Lifesciences (EW) Q2 Earnings Top Estimates, View Up

June 16, 2023 | wsj.com

Mega Lifesciences PCL

May 10, 2023 | wsj.com

Zydus Lifesciences Ltd.

April 4, 2023 | proactiveinvestors.com.au

Innovation begins with collaboration: Steven Lydeamore

March 29, 2023 | finance.yahoo.com

Anatara Lifesciences Ltd (ANR.AX)

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 11, 2023 | benzinga.com

Edwards Lifesciences Stock (NYSE:EW), Dividends

September 21, 2022 | reuters.com

Anatara Lifesciences Ltd

September 7, 2021 | investing.com

Anatara Lifesciences Ltd (ANR)

September 6, 2021 | sg.finance.yahoo.com

Anatara Lifesciences Limited (ANR.AX) Meet the CEO Investor Webinar

September 6, 2021 | uk.finance.yahoo.com

Anatara Lifesciences Limited (ANR.AX) Investor Presentation

August 20, 2021 | au.finance.yahoo.com

Anatara Lifesciences Limited (ANR.AX) Launches IBS-D Clinical Trial Recruitment Website

August 6, 2021 | au.finance.yahoo.com

Anatara Lifesciences Limited (ANR.AX) Successful Piglet Study

July 28, 2021 | uk.finance.yahoo.com

Anatara Lifesciences Limited (ANR.AX) Monthly Activities Report

See More Headlines

Receive ANR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anatara Lifesciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: ASX:ANR
CUSIP: N/A
CIK: N/A
Web: www.anataralifesciences.com
Phone: 61 7 3394 8202
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,750,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -117.14%
Return on Assets: -65.37%

Debt

Debt-to-Equity Ratio: 3.24
Current Ratio: 8.90
Quick Ratio: 4.69

Sales & Book Value

Annual Sales: $1.25 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 2.33
Book Value: A$0.01 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 167,890,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.65

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. David Lionel Brookes F.A.C.I.D. (Age 64)
FACRRM, FAICD, MBBS, Executive Chairman
Comp: $168.21k
Mr. John Michailidis B.Sc.
EMBA, M.A.I.C.D., COO & Executive Director
Mr. Simon Erskine
Chief Development Officer
Jane Lowe
Managing Director of IR Department
Dr. Stephen Denaro AGIA
BCom, CA, GradDipApp CG, MAICD, Company Secretary
Ms. Hayley van der Meer B Biomed Sc
Grad Dip Marketing Management, Commercial Manager

Key Competitors

View All Competitors

Insiders

ANR Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Anatara Lifesciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Anatara Lifesciences investors own include Woodside Petroleum (WPL), Temple & Webster Group (TPW), Brompton Oil Split (OSP), Eagle Materials (EXP), BHP Group (BHP) and Ameriprise Financial (AMP).

This page (ASX:ANR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial